New research by NIH-funded scientists has revealed evidence that viral species, particularly herpesviruses, could contribute toward the complex biology underlying Alzheimer’s disease.
Browsing: Alzheimer’s disease
To mark The Longest Day campaign by the Alzheimer’s Association, we’ve brought together all our Alzheimer’s disease content for you to browse.
An independent data monitoring committee has advised that lanabecestat is unlikely to meet primary endpoints, leading to the decision to discontinue trials.
Alzheimer’s Society has worked with an expert taskforce to develop goals and detailed recommendations for research into dementia prevention, diagnosis, intervention and care by 2025.
Researchers have uncovered three new genes that are linked to the possibility of developing Alzheimer’s disease; potentially unlocking new treatment possibilities for patients.
A recent trial has determined that moderate-to-high intensity exercise does not slow cognitive decline in individuals with dementia.
Researchers have suggested that anti-amyloid therapies would be most effective before individuals reach the threshold for preclinical Alzheimer’s disease.
In this week’s industry news round-up we set the focus on Alzheimer’s disease (AD), with another clinical trial termination announced and a new framework for defining AD.
New research has suggested that a protein involved in Alzheimer’s disease may also be implicated in HIV-associated neurological disorders, suggesting Alzheimer’s therapies may benefit a subset of HIV patients.
Prof Spires-Jones chats to Lauren Pulling about synapse degeneration in Alzheimer’s, as well as the importance of mentoring in science.